Oncology Corporate Profile
5.8650 | |
0.5850 |
MannKind Corporation focuses on the discovery, development and commercialization of therapeutic products for patients with diseases such as diabetes and cancer.
Website: http://www.mannkindcorp.com/
Brand / Product | Class | Area of Study | Phase | Partnership |
---|---|---|---|---|
MKC1106 | immunotherapy | 1st line metastatic Melanoma | II | |
MKC204 | IRE-1 Inhibitor | Multiple Myeloma | Preclinical |